|
|
Article: MONEY BRIEFS.(MONEY)
- Article from:
- Telegram & Gazette (Worcester, MA)
- Article date:
- November 11, 2009
CopyrightCOPYRIGHT 2009 Worcester Telegram & Gazette. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
COLUMN: MONEY BRIEFS
Drug firms collaborate
NEW YORK - Bristol-Myers Squibb Co. and Alder Biopharmaceuticals Inc. said yesterday they signed a collaboration deal potentially worth $1 billion, with a key focus on a rheumatoid arthritis treatment. Bristol-Myers will pay Alder $85 million up front for ALD518, which is now past midstage development for rheumatoid arthritis, an inflammatory condition that can cause joint damage. The agreement also includes the potential for development-based and regulatory-based milestone payments of up to $764 million and sales-based milestones that could be more than $200 million.
Bristol-Myers already sells the ...
Related newspaper, magazine, and journal articles:
|
|
Article: Babcock Power Acquires Assets of Welding ...
Business Wire;
September 1, 2009 ;
700+ words
...DANVERS, Mass. -- Babcock Power Inc. ("BPI") announced today that its subsidiary, Babcock Power Services Inc. ("Babcock Power Services"), has acquired all assets of Welding Technologies Inc. located in Gainesville, Georgia. Welding ...
|
|